604 Fibrosis progression in 914 HIV-HCV co-infected patients is strongly related with age: an European collaborative study

Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 453-453
Author(s):  
L MARTINCARBONERO ◽  
J GARCIASAMANIEGO ◽  
Y BENHAMOU ◽  
M ROMERO ◽  
M PUOTI ◽  
...  
Keyword(s):  
Collaborative Study ◽  
Fibrosis Progression ◽  
European Collaborative Study

scholarly journals Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

1997 ◽  
Vol 34 (10) ◽  
pp. 798-804 ◽  
Author(s):  
A K Ryan ◽  
J A Goodship ◽  
D I Wilson ◽  
N Philip ◽  
A Levy ◽  
...  
Keyword(s):  
Clinical Features ◽  
Collaborative Study ◽  
Chromosome 22Q11 ◽  
European Collaborative Study

Conditioning of drug-induced immunomodulation in human volunteers: A European Collaborative Study

1992 ◽  
Vol 31 (4) ◽  
pp. 459-472 ◽  
Author(s):  
C. Kirschbaum ◽  
L. Jabaaij ◽  
A. Buske-Kirschbaum ◽  
J. Hennig ◽  
M. Blom ◽  
...  
Keyword(s):  
Collaborative Study ◽  
Drug Induced ◽  
Human Volunteers ◽  
European Collaborative Study

scholarly journals A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis

Blood ◽  
2015 ◽  
Vol 126 (5) ◽  
pp. 612-615 ◽  
Author(s):  
Giovanni Palladini ◽  
Sajitha Sachchithanantham ◽  
Paolo Milani ◽  
Julian Gillmore ◽  
Andrea Foli ◽  
...  
Keyword(s):  
High Risk ◽  
Collaborative Study ◽  
Al Amyloidosis ◽  
Excellent Outcome ◽  
Heart Damage ◽  
High Risk Patients ◽  
Key Points ◽  
Risk Patients ◽  
European Collaborative Study

Key Points CyBorD achieves excellent outcome in noncardiac patients with AL amyloidosis and can rescue subjects with reversible heart damage. The outcome of high-risk patients remains poor, but response to CyBorD can also improve survival in this group.

Sign in / Sign up

Export Citation Format

Share Document